Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome

Physiological Research

Volumn 55, Issue 5, 2006, Pages 483-490

  Stancakova A ^a   Baldaufova L ^a   Javorsky M ^a   Kozarova M ^a   Salagovic J ^a   Tkáč, Ivan ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Apolipoprotein B; Dyslipidemia; Genetic polymorphisms; Metabolic syndrome

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN C3; CHOLESTEROL ESTER TRANSFER PROTEIN; LIPOPROTEIN; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DYSLIPIDEMIA; FEMALE; G250A GENE; GENE; GENOTYPE; HINDIII GENE; HUMAN; LINEAR REGRESSION ANALYSIS; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PVUII GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SSTI GENE; TAQ1B GENE;

EID: 33750262366     PISSN: 08628408     EISSN: 08628408     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. AHN YI, KAMBOH MI, HAMMAN RF, COLE SA, FERRELL RE: Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J Lipid Res 34: 421-428, 1993.
2. BOEKHOLDT SM, SACKS FM, JUKEMA JW, SHEPHERD J, FREEMAN DJ, MCMAHON AD, CAMBIEN F, NICAUD V, DE GROOTH GJ, TALMUD PJ, HUMPHRIES SE, MILLER GJ, EIRIKSDOTTIR G, GUDNASON V, KAUMA H, KAKKO S, SAVOLAINEN MJ, ARCA M, MONTALI A, LIU S, LANZ HJ, ZWINDERMAN AH, KUIVENHOVEN JA, KASTELEIN JJ: Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation 111: 278-287, 2005.
3. BROUSSEAU ME, O'CONNOR JJ Jr, ORDOVAS JM, COLLINS D, OTVOS JD, MASSOV T, MCNAMARA JR, RUBINS HB, ROBINS SJ, SCHAEFER EJ: Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial. Arterioscler Thromb Vasc Biol 22: 1148-1154, 2002.
4. BRUNS GA, KARANTHASIS SK, BRESLOW JL: Human apolipoprotein AI-CIII gene complex is located on chromosome 11. Arteriosclerosis 4: 97-102, 1984.
5. CHHABRA S, NARANG R, KRISHAN LR, VASISHT S, AGARWAL DP, SRIVASTAVA LM, MANCHANDA SC, DAS N: Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians. BMG Genetics 3: 9, 2002.
6. DALLONGEVILLE J, MEIRHAEGHE A, COTTEL D, FRUCHART JC, AMOUYEL P, HELBECQUE N: Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France. Atherosclerosis 150: 149-157, 2000.
7. DE LORENZO F, MONTICELLI A, COCOZZA S, DE SIMONE B, RUBBA P: Extracoronary atherosclerosis and genetic variants of apolipoprotein AI-CIII cluster in myocardial infarction survivors from southern Italy. Clin Invest. 72: 435-441, 1994.
8. DURLACH A, CLAVEL C, GIRARD-GLOBA A, DURLACH V: Sex-dependent association of a genetic polymorphism of cholesteryl ester transfer protein with high-density lipoprotein cholesterol and macrovascular pathology in type II diabetic patients. J Clin Endocrinol Metab 84: 3656-3659, 1999.
9. ELKELES RS, DIAMOND JR, POULTER C, DHANJIL S, NICOLAIDES AN, MAHMOOD S, RICHMOND W, MATHER H, SHARP P, FEHER MD: Cardiovascular outcomes in type 2 diabetes. A double-blind placebocontrolled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study. Diabetes Care 21: 641-648, 1998.
10. FESTA A, D'AGOSTINO R JR, HOWARD G, MYKKANEN L, TRACY RP, HAFFNER SM: Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102: 42-47, 2000.
11. FREEMAN DJ, PACKARD CJ, SHEPHERD J, GAFFNEY D: Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer protein activity. Clin Sci 79: 575-581, 1990.
12. FUMERON F, BETOULLE D, LUC G, BEHAGUE I, RICARD S, POIRIER O, JEMAA R, EVANS A, ARVEILER D, MARQUES-VIDAL P, BARD JM, FRUCHART JC, DUCIMETIERE P, APFELBAUM M, CAMBIEN F: Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 96: 1664-1671, 1995.
13. GAVISH D, LEIBOVITZ E, SHAPIRA I, RUBINSTEIN A: Bezafibrate and simvastatin combination therapy for diabetic dyslipidaemia: efficacy and safety. J Intern Med 247: 563-569, 2000.
14. GEORGES JL, REGIS-BAILLY A, SALAH D, RAKOTOVAO R, SIEST G, VISVIKIS S, TIRET L: Family study of lipoprotein lipase gene polymorphisms and plasma triglyceride levels. Genet Epidemiol 13: 179-192, 1996.
15. GERDES C, GERDES LU, HANSEN PS, FAERGEMAN O: Polymorphismsin the lipoprotein lipase gene and their associations with plasma lipid concentrations in 40-year-old Danish men. Circulation 92: 1765-1769, 1995.
16. GINSBERG HN, HUANG LS: The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis. J Cardiovasc Risk 7: 325-331, 2000.
17. GOLDBERG IJ: Lipoprotein lipase and lipolysis: central roles in lipopprotein metabolism and atherogenesis. J Lipid Res 37: 693-707, 1996.
18. GOTODA T, YAMADA N, MURASE T, SHIMANO H, SHIMADA M, HARADA K, KAWAMURA M, KOZAKI K, YAZAKI Y: Detection of three separate DNA polymorphisms in the human lipoprotein lipase gene by gene amplification and restriction endonuclease digestion. J Lipid Res 33: 1067-1072, 1992.
19. GROOP L, EKSTRAND A, FORSBLOM C, WIDEN E, GROOP PH, TEPPO AM, ERIKSSON J: Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36: 642-647, 1993.
20. GUDNASON V, KAKKO S, NICAUD V, SAVOLAINEN MJ, KESÄNIEMI YA, TAHVANAINEN E, HUMPHRIES S: Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS group. Eur J Clin Invest 29: 116-128, 1999.
21. HEGELE RA, LITTLE JA, VEZINA C, MAGUIRE GF, TU L, WOLEVER TS, JENKINS DJ, CONNELLY PW: Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb 13: 720-728, 1993.
22. HEIZMANN C, KIRCHGESSNER T, KWITEROVICH PO, LADIAS JA, DERBY C, ANTONARAKIS SE, LUSIS AJ: DNA polymorphism haplotypes of the human lipoprotein lipase gene: possible association with high density lipoprotein levels. Hum Genet 86: 578-584, 1991.
23. HOFFER MJV, SIJBRANDS EJG, DE MAN FHAF, HAVEKES LM, SMELT AHM, FRANTS RR: Increased risk for endogenous hypertriglyceridaemia is associated with an apolipoprotein C3 haplotype specified by the SstI polymorphism. Eur J Clin Invest 28: 807-812, 1998.
24. JEMAA R, FUMERON F, POIRIER O, LECERF L, EVANS A, ARVEILER D, LUC G, CAMBOU JP, BARD JM, FRUCHART JC, APFELBAUM M, CAMBIEN F, TIRET L: Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J Lipid Res 36: 2141-2146, 1995a.
25. JEMAA R, TUZET S, PORTOS C, BETOULLE D, APFELBAUM M, FUMERON F: Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people. Int J Obes 19: 270-274, 1995b.
26. KARATHANASIS SK: Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII and AIV genes. Proc Natl Acad Sci USA 82: 6374-6378, 1985.
27. KUIVENHOVEN JA, DE KNIJFF P, BOER JMA, SMALHEER HA, BOTMA GJ, SEIDELL JC, KASTELEIN JJ, PRITCHARD PH: Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol 17: 560-568, 1997.
28. LAMARCHE B, TCHERNOF A, MAURIEGE P, CANTIN B, DAGENAIS GR, LUPIEN PJ, DESPRES JP: Fasting insulin and apolipoprotein B levels and low density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 279: 1955-1961, 1998.
29. MARCIL M, BOUCHER B, GAGNE E, DAVIGNON J, HAYDEN M, GENEST J: Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects. J Lipid Res 37: 309-319, 1996.
30. MATTU RK, NEEDHAM EWA, MORGAN R, REES A, HACKSHAW AK, STOCKS J, ELWOOD PC, GALTON DJ: DNA variants at the LPLgene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler Thromb 14: 1090-1097, 1994.
31. ORDOVAS JM, CIVEIRA F, GENEST JJ, CRAIG S, ROBBINS AH, MAEDE T, POCOVI M, FROSSARD PM, MASHARANI U, WILSON PWF, SALEM DN, WARD RH, SCHAEFER EJ: Restriction fragment length polymorphisms of the apolipoprotein AI-CIII-AIV gene locus. Atherosclerosis 87: 75-86, 1991.
32. ORDOVAS J, CUPPLES LA, CORELLA D, OTVOS JD, OSGOOD D, MARTINEZ A, LAHOZ C, COLTELL O, WILSON PW, SCHAEFER EJ: Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol 20: 1323-1329, 2000.
33. PRICE WH, MORRIS SW, BURGON R, DONALD PM, KITCHIN AH. ApolipoproteinCIII polymorphism and coronary heart disease. Lancet 2: 1041, 1986.
34. REAVEN GM. Syndrome X: 6 years later. J Intern Med Suppl.736: 13-22, 1994.
35. RUSSO GT, MEIGS JB, CUPPLES LA, DEMISSIE S, OTVOS JD, WILSON PW, LAHOZ C, CUCINOTTA D, COUTURE P, MALLORY T, SCHAEFER EJ, ORDOVAS JM: Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis 158: 173-181, 2001.
36. SHOULDERS CC, GRANTHAM TT, NORTH JD, GASPARDONE A, TOMAI F, DE FAZIO A, VERSACI F, GIOFFRE PA, COX NJ: Hypertriglyceridemia and the apolipoprotein CIII gene locus: lack of association with the variant insulin response element in Italian school children. Hum Genet 98: 557-566, 1996.
37. SHOULDERS CC, NAUMOVA RP: USF1 implicated in the aetiology of familial combined hyperlipidaemia an the metabolic syndrome. Trends Mol Med 10: 362-365, 2004.
38. STOCKS J, PAUL-HAYASE H, GALTON DJ. Haplotypes identified by DNA restriction-fragment-length polymorphisms in the A-I C-III A-IV gene region and hypertriglyceridemia. Am J Hum Genet 41: 106-118, 1987.
39. TALMUD PJ, HUMPHRIES SE. Apolipoprotein C-III gene variation and dyslipidaemia. Curr Opin Lipidol 8: 154-158, 1997.
40. THORN JA, CHAMBERLAIN JC, ALCOLADO JC, OKA K, CHAN L, STOCKS J, GALTON DJ: Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis. Atherosclerosis 85: 55-60, 1990.
41. TYBJAERG-HANSEN A, NORDESTGAARD BG, GERDES LU, FAERGEMAN O, HUMPHRIES SE: Genetic markers in the apoAI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis. Atherosclerosis 100: 157-169, 1993.
42. VOHL MC, LAMARCHE B, MOORJANI S, PRUD'HOMME D, NADEAU A, BOUCHARD C, LUPIEN PJ, DESPRES JP: The lipoprotein lipase HindIII polymorphism modulates plasma triglyceride levels in visceral obesity. Arterioscler Thromb Vasc Biol 15: 714-720, 1995.
43. WAGNER AM, PEREZ A, CALVO F, BONET R, CASTELLVI A, ORDONEZ J: Apolipoprotein(B) identifies dyslipidemic Phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients. Diabetes Care 22: 812-817, 1999.
44. WANG C, MCCONATHY WJ, KLOER HU, ALAUPOVIC P: Modulation of lipoprotein lipase activity by apolipoproteins. J Clin Invest 75: 384-390, 1985.
45. YAMASHITA S, HIRANO K, SAKAI N, MATSUZAWA Y: Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein. Biochim Biophys Acta 1529: 257-275, 2000.
46. YILMAZ H, AGACHAN B, KARAALI ZE, ISBIR T: Taq1B polymorphism of CETP gene on lipid abnormalities in patients with type II diabetes mellitus. Int J Mol Med 13: 889-893, 2004.
47. ZAMBON A, DEEB SS, HOKANSON JE, BROWN BG, BRUNZELL JD: Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol 18: 1723-1729, 1998.